HRT Financial’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$704K Buy
+554,800
New +$1.04M ﹤0.01% 2286

Other funds holding HCAT

HRT Financial's HCAT Position: Q1 2026 in Review

HRT Financial increased its Health Catalyst (HCAT) stake by 1,824% in Q1 2026, buying an estimated $434K and bringing the position to 243,191 shares worth $308K. The position accounts for ﹤0.01% of the portfolio, ranked #2855.

HRT Financial first reported a position in HCAT in Q1 2022 and has held it in 8 quarters since. The position peaked at $1.77M in Q4 2023. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • HRT Financial held 243,191 shares of Health Catalyst worth $308K as of Q1 2026.
  • HRT Financial bought 230,553 Health Catalyst shares in Q1 2026, an estimated $434K.
  • Health Catalyst made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #2855 holding.
  • HRT Financial first reported a position in Health Catalyst in Q1 2022 and has held it in 8 quarters since.
  • HRT Financial's Health Catalyst position peaked at $1.77M in Q4 2023.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.